Recon: Merck's Keytruda Picks up Two New Indications for Head a...
06/11/19
Recon: Merck's Keytruda Picks up Two New Indications for Head and Neck Cancer Regulatory Focus
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Merck's Keytruda wins FDA approval to treat head ...
[more]